Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.
Terashima M, Fujiwara H, Takagane A, Abe K, Irinoda T, Nakaya T, Yonezawa H, Oyama K, Saito K, Kanzaki N, Ohtani S, Nemoto T, Hoshino Y, Kogure M, Gotoh M.
Terashima M, et al. Among authors: yonezawa h.
Gastric Cancer. 2003;6 Suppl 1:71-81. doi: 10.1007/s10120-003-0221-z.
Gastric Cancer. 2003.
PMID: 12775024
Clinical Trial.